جست‌وجوی استاد و پژوهشگر

Juan Pablo Lopezمشاهده پروفایل

استادیار

• Neurosciences
• Psychiatry
• Molecular mechanisms of psychiatric disorders
• +۴ مورد دیگر

Dr. Juan Pablo Lopez is an Assistant Professor at the Department of Neuroscience, Karolinska Institutet (Sweden) , leading research on stress-related psychiatric disorders. He earned undergraduate degrees in Psychology and Biology (Florida International University), a PhD in Psychiatry (McGill University), and postdoctoral training at the Max Planck Institute of Psychiatry in Munich. His work combines single-cell transcriptomics behavioral mouse models automated behavioral tracking viral-mediated gene manipulations to study stress susceptibility, resilience, and antidepressant mechanisms. Research interests include: Neurobiology of stress and trauma Molecular mechanisms in psychiatric disorders Developmental neuroendocrinology Sex differences in stress response Neural circuits of depression His recent work analyzes how stress exposure during development influences lifelong mental health and treatment outcomes. Scientific accolades include 2023 ECNP Rising Star Award ERC Starting Grant (2023) Swedish Research Council Starting Grant (VR, MH-12) StratNeuro Startup Funding He leads the Lopez Lab, which collaborates with international groups through the NeSTED network (Neuropharmacology and Stress/Trauma Exposure during Development).

• Adrenal Development
• Reproductive Development
• Transcriptomics
• +۱۰ مورد دیگر

Prof John Achermann is a Clinical Professor of Paediatric Endocrinology at the Genetics & Genomic Medicine Department , University College London (UCL), with an active role at the UCL GOS Institute of Child Health since 2023. His career spans clinical and research expertise in adrenal and sex development , genetic mechanisms of disease , and nuclear receptor biology , highlighted by over 200 publications and an h-index of 67. Education: Bachelor of Arts (Honours), University of Cambridge (1988) Bachelor of Medicine, University of Cambridge (1990) Master of Arts, University of Cambridge (1992) Doctor of Medicine (MD), University of Cambridge (1997) Doctor of Philosophy (PhD), University of Cambridge (2011) His research focuses on molecular genetics of adrenal and reproductive development , integrating transcriptomics and genomic medicine to understand disorders like Turner syndrome, Disorders of Sex Development (DSD), and adrenal insufficiency. Recent work includes single-cell analyses of fetal gonads , exome sequencing for DSD/POI , and NR5A1/SRY regulatory mechanisms . Key awards include the 2025 ESPE Research Award , 2023 Henning Andersen Prize , and 2016 Clinical Endocrinology Trust Lecturer Medal . Scientific Awards: ESPE Research Award (2025) Henning Andersen Prize (2023, 2007) Clinical Endocrinology Trust Lecturer Medal (2016) SPARKS/RCPCH Young Investigator (2007) ESPE Young Investigator (2002) Noble Prize for MD Thesis (1998) As Head of the Molecular Basis of Rare Disease Section and Deputy Head of Genetics & Genomic Medicine at UCL GOS Institute of Child Health, he bridges clinical practice with translational research. He contributes to undergraduate and postgraduate medical education , supervises MSc projects, and serves on the ESPE Local Organising Committee for 2024. His work aligns with UN Sustainable Development Goals for Good Health & Well-Being and Gender Equality .

Kaitlin J. Bashamمشاهده پروفایل

پژوهشگر

• Cellular Senescence
• Developmental Biology
• Adrenal Cancer
• +۲ مورد دیگر

Kaitlin J. Basham, PhD, is a researcher in the Department of Oncological Sciences at the University of Utah. Her work focuses on adrenal cancer, cellular senescence, and developmental biology using mouse models and Wnt pathway analysis. Postdoctoral Fellowship: University of Michigan (Endocrine Cancer) PhD: University of Utah BS: Saint Mary’s College of California Her research explores: Adrenal cancer progression mechanisms Non-canonical Wnt signaling in endocrine tumors Senescence-induced immune remodeling Age-related changes in adrenal cortex Androgen receptor roles beyond prostate cancer Stem cell dynamics in adrenal physiology Basham Lab at the Huntsman Cancer Institute emphasizes inclusive training environments and developing less toxic adrenal cancer therapies through collaborative research.

Marian L. Logripمشاهده پروفایل

دانشیار

• Addiction Neuroscience
• Stress-Alcohol Interactions
• Sex Differences in Neurobiology
• +۳ مورد دیگر

Marian L. Logrip is an Associate Professor at the Department of Neuroscience, School of Science, Indiana University in Indianapolis. Her research focuses on understanding how stress and alcohol consumption interact, particularly emphasizing sex differences in neural adaptations to these factors. She investigates mechanisms underlying stress-related neuropsychiatric disorders and alcohol use, with a special interest in long-term effects of trauma on neurocircuitry and addiction comorbidity. Dr. Logrip holds a Ph.D. in Neuroscience from the University of California, San Francisco (2007) and a B.S. in Economics from the University of Pennsylvania (1997). She also completed postdoctoral training as a Research Associate and later Senior Research Associate at The Scripps Research Institute (2007–2015). Her research interests include molecular and circuit-level adaptations in the brain due to stress and alcohol exposure, identifying sex-specific differences in these processes, and exploring therapeutic targets for anxiety and addiction. Key areas involve phosphodiesterase regulation, corticosterone sensitivity, and the role of CRF in addiction neurobiology. Dr. Logrip collaborates with institutions like the Indiana Alcohol Research Center and Stark Neurosciences Research Institute. She advises students in her lab and has contributed to studies on glucocorticoid receptor antagonism in alcohol dependence and computational models of alcohol's impact on fear conditioning. Her work examines how environmental factors (e.g., housing conditions) influence alcohol-related behaviors and stress responses, with recent studies addressing PTSD models in rodents and sex-specific timelines of neuroadaptations. Dr. Logrip’s research bridges basic neuroscience with translational medicine, aiming to improve treatments for comorbid disorders.

Tatiana Novoselovaمشاهده پروفایل

مدرس

• Neurodegenerative disorders
• Ataxias
• Metabolic regulation
• +۴ مورد دیگر

Dr. Tatiana Novoselova serves as a Lecturer in Medical Sciences at the Institute of Health Sciences Education (IHSE) within Queen Mary University of London's Faculty of Medicine and Dentistry. She co-leads the Metabolism module for Phase 1 of the MBBS program and acts as Senior Internal Examiner for Year 2 Paper B, while teaching Metabolism and Brain and Behaviour modules across Year 1-2 MBBS and Graduate Entry Programme cohorts. Her educational background includes an MBBS from a top Russian medical school, followed by a PhD in Molecular and Cellular Neuroscience at University College London. This foundation supports her dual expertise in clinical education and laboratory research. Novoselova's research centers on molecular mechanisms of neurodegenerative disorders and ataxias, with significant contributions to understanding central metabolic regulation, obesity pathophysiology, and adrenal gland physiology. Her work bridges neuroscience and endocrinology through investigations of melanocortin receptor signaling, mitochondrial dysfunction in optic atrophy, and adrenal zonation defects. Analysis of her 15 most recent publications (2013-2022) reveals a consistent focus on genetic and molecular underpinnings of disease, utilizing iPSC models, multi-omic profiling, and animal studies. Key thematic clusters include optic atrophy mechanisms (OPA1-related), adrenal insufficiency genetics (MRAP/NNT pathways), and obesity-related neural circuits (melanocortin systems), demonstrating translational approaches from basic science to therapeutic strategies. No scientific awards, prizes, fellowships, or medals were documented in the source material. During her tenure at Middlesex University London, Novoselova supervised MSc and PhD students while leading the MSc Computational Neuroscience program. Current advising roles at Queen Mary include Senior Tutor and Academic Adviser for MBBS students, though specific grant funding details remain unreported. Her academic leadership extends to REF2021 contributions and ethics committee service. While collaborative research networks are evident through co-authored publications on adrenal physiology and neurodegeneration, explicit laboratory affiliations or dedicated research teams at Queen Mary were not specified in the available documentation.

Leonardo Guastiمشاهده پروفایل

استاد

• Experimental Endocrinology
• Adrenal Cortex Development
• Steroidogenesis
• +۴ مورد دیگر

Professor Leonardo Guasti is a Professor in Experimental Endocrinology at Queen Mary University of London's William Harvey Research Institute (WHRI) Centre for Endocrinology. He holds affiliations within the Faculty of Medicine and Dentistry and collaborates with institutions like the UCL Institute of Child Health and Technical University of Dresden. Education: BSc Biological Sciences & MS in Pathophysiology (1999), University of Florence, Italy PhD in Clinical and Experimental Oncology (University of Florence), with Fulbright Distinguished Fellowship at University of Tulsa, USA Research Focus: Adrenal cortex development and function, including steroidogenic cell reprogramming Molecular mechanisms in adrenocortical carcinogenesis (ACC), focusing on DLK1-expressing cell clusters and WNT/b-Catenin pathways Translational strategies for adrenal insufficiency using induced pluripotent stem cells Awards & Recognition: Accademia Nazionale dei Lincei Fellowship Telethon Fellowship Fulbright Distinguished Fellowship Advising & Grants: Supervised multiple PhD/postdoctoral researchers (listed in students field). Active grants include funding from Barts Charity, Rosetrees Trust, MRC, and BBSRC. Current team includes Dr James Pittaway (MRC Fellow) and Dr Katia Mariniello (Barts Charity Fellow). Collaborations: Partnerships with Prof Stefan Bornstein (Technical University of Dresden), Prof Celso Gomez-Sanchez (University of Mississippi), and Dr Olivia Crociani (University of Florence).

• Signaling Mechanisms
• Tissue Homeostasis
• Tumorigenesis
• +۵ مورد دیگر

Junhao Mao is a Professor in the Department of Molecular, Cell and Cancer Biology at UMass Chan Medical School and T.H. Chan School of Medicine. His research focuses on signaling mechanisms in tissue homeostasis and tumorigenesis, particularly the Hippo, Wnt, and Hedgehog pathways. Education : PhD in Pharmacology from University of Rochester (2003), Postdoc in Developmental Biology at Harvard University (2003-2008) Awards : Charles H. Hood Foundation Child Health Research Award (2009), American Cancer Society Research Scholar Award (2011), Pancreatic Cancer Alliance Research Award (2015), Sanofi iAward (2020) Research Interests : His lab investigates how dysregulation of developmental signaling pathways contributes to tumor initiation and progression, using molecular, cellular, and mouse genetic approaches. Recent work highlights roles of Hippo pathway components in sarcoma, pancreatic cancer, and intestinal homeostasis. Publications : 15 most recent articles span topics in cancer biology, stem cell regulation, and developmental signaling. Key themes include Hippo-Wnt-Hedgehog cross-talk, YAP/TAZ-driven oncogenesis, and mechanistic studies in tumor suppression. Contact : Junhao.Mao@umassmed.edu | 508-856-4149

Stefan Richard Bornsteinمشاهده پروفایل

استاد

• Islet Transplantation
• Metabolic Disease
• Internal Medicine
• +۲ مورد دیگر

Stefan Richard Bornstein is a full Professor, Director of the Department of Medicine, and Chair at the University Clinic Carl Gustav Carus Dresden. He serves as International Dean at Technische Universität Dresden and TransCampus Dean at King’s College London . His career spans multiple leadership roles, including budget oversight for €500M+ operations (2014-2016). Medical training at University of Ulm and University of Miami Residency at University of Ulm (1988-1994) Research focuses on endocrine-immune crosstalk , islet transplantation , and metabolic disease mechanisms , with 800+ publications and high citation metrics (h-index 88/106). His work bridges clinical practice with translational science. Publication themes include: SARS-CoV-2 impacts on endocrine/metabolic systems (2020-2022) Stress-induced stem cell plasticity (2018) Adipocyte-lipid hypertension mechanisms (2003-2009) Islet transplantation strategies (2013-2017) Immune-endocrine adrenal crosstalk (1998-2004) Selected honors: Order of Merit of the Federal Republic of Germany (2018) Medal of Honor of TU Dresden (2021) Leopoldina Academy membership (2010) DFG Heisenberg Grant (1996-1999) Marius-Tausk Award (1994) First Prize for new academics (Baden-Württemberg) He established the TransCampus initiative linking King’s College London and TU Dresden for joint PhD/MD programs and clinical-science partnerships. The Medicine Department under his leadership became TUD's top performer in publications and competitive funding over the last 15 years.

Meltem Wegerمشاهده پروفایل

پژوهشگر ارشد

• Circadian Rhythms
• Metabolic Physiology
• Endocrine Pathophysiology
• +۳ مورد دیگر

Dr Meltem Weger is a Research Fellow at the Institute for Molecular Bioscience (IMB), University of Queensland. Her research focuses on circadian rhythms' roles in (patho-)physiology, particularly liver metabolism and endocrine systems. She holds a PhD from Heidelberg University (2013) and completed postdoctoral work at Birmingham University and École Polytechnique Fédérale de Lausanne (EPFL). Key research interests include circadian-glucocorticoid interactions, metabolic homeostasis, and chronodisruption in liver disease. Her work spans molecular and cellular biology approaches, including omics technologies to study metabolic changes in stress-related conditions and circadian clock disruptions. Notable contributions include elucidating how circadian clocks regulate liver gene expression and metabolic pathways, with implications for drug discovery and disease mechanisms. Collaborations involve multidisciplinary teams investigating circadian rhythms in renal physiology, drug timing strategies, and stress-induced pathologies. Recent studies highlight maternal high-fat diet effects on offspring metabolism through circadian-independent endocrine changes, and the role of renal tubular circadian clocks in systemic metabolism. She contributes to projects like the NHMRC grant on microbiota-growth hormone axes and liver disease mechanisms.

• Pediatric Surgery
• Minimally Invasive Surgery
• Thoracic Surgery
• +۳ مورد دیگر

Michael G. Caty, MD, MMM, is the Robert Pritzker Professor of Surgery and Pediatrics at Yale School of Medicine, serving as Chief of the Section of Pediatric Surgery and Surgeon-in-Chief at Yale-New Haven Children's Hospital since 2012. His expertise spans neonatal surgery, thoracic surgery, intestinal motility disorders, and minimally invasive pediatric procedures. BS, Boston College (1981) MD, University of Massachusetts Medical School (1985) Residency, University of Michigan Hospitals (1991) Fellowship, Children’s Hospital of Boston (1993) MMM, Carnegie Mellon University (2010) Dr. Caty focuses on complex pediatric surgeries, particularly tracheal/esophageal interventions and ano-rectal malformation reconstruction. His research explores surgical education frameworks, informed consent methodologies, and cross-disciplinary links between endocrine disorders (e.g., polycystic ovarian syndrome) and surgical pathologies (e.g., pilonidal disease). His 2020–2025 publications highlight quality improvement in appendicitis care, neonatal cardiothoracic interventions, and endocrine surgical outcomes. Articles emphasize minimally invasive techniques, multidisciplinary approaches, and postoperative complication management. Arnold M. Salzberg Mentorship Award (2024) David J. Leffell Prize for Clinical Excellence (2022) America's Top Doctors (2013–2020) Best Doctors in America (2013–2020) Kaleida Health Spirit Award (2017) Promising Inventor Award (2005) Dr. Caty is a leader in pediatric surgery societies, former President of the Pediatric Surgery Biology Club, and Chair of the Organization of Children’s Hospital Surgeons-in-Chief. He edited the textbook Complications in Pediatric Surgery , reflecting his commitment to surgical education and clinical excellence.

Gary D. Hammerمشاهده پروفایل

استاد

• Endocrinology
• Adrenal Cancer Research
• Stem Cell Biology
• +۵ مورد دیگر

Dr. Gary D. Hammer is Professor in the Department of Internal Medicine (Metabolism, Endocrinology, and Diabetes), Cell & Developmental Biology, and Molecular & Integrative Physiology at the University of Michigan Medical School. He serves as Director of the Endocrine Oncology Program in Rogel Cancer Center where he holds the Millie Schembechler Professorship in Adrenal Cancer, and was previously Director of the Center for Organogenesis: Stem Cells & Regenerative Medicine. Dr. Hammer's research focuses on elucidating the mechanisms by which growth factor signaling and transcriptional programs initiate adrenal-specific growth and differentiation, with emphasis on dysregulated adrenocortical stem cells in development and homeostasis. His work has implications for regenerative medicine and cancer treatment, particularly for adrenal diseases. He has brokered the recent renaissance of the Michigan team of adrenal scientists that includes leading researchers in adrenal disease. His extensive publication record shows a consistent focus on adrenal biology, stem cell regulation, and cancer mechanisms, with recent work exploring β-catenin functions, epigenetic subtyping of adrenal cancer, and adrenocortical stem cells. His research often involves international collaborations, including the A5 (American Australian Asian Adrenal Alliance) that he helped form. UofM Jerome Conn Award for Outstanding Research in Internal Medicine Endocrine Society Edwin B. Astwood Award for Outstanding Research Member of ASCI and AAP Editor of four textbooks including Pathophysiology of Disease: An Introduction to Clinical Medicine Adrenal Section Editor for Degroot's Endocrinology Dr. Hammer has served in numerous leadership roles at the University of Michigan and in professional organizations, including as President of the Endocrine Society (2020-2021). He served on the Board of Scientific Advisors for NCI and as an Advisor to the Congressional H.E.L.P. committee, co-authoring the 21st Century Cancer ALERT Act. He co-founded two companies - MILLENDO and SLING THERAPEUTICS - that focus on rare endocrine diseases. His laboratory work has led to new national and international therapeutic trials with biological-based therapies for adrenal cancer. Dr. Hammer leads the Endocrine Oncology Program at Rogel Cancer Center and has formed international cooperative groups including the A5 Adrenal Alliance. His work with colleagues has catalyzed collaboration to secure projects from Pharma and funding agencies across the spectrum of adrenal diseases, resulting in new therapeutic approaches that target molecular defects in endocrine disease while sparing normal tissue.

Chen-Che Huangمشاهده پروفایل

دانشیار

• Developmental Biology
• Endocrinology
• Molecular Biology
• +۲ مورد دیگر

Dr. Chen-Che Huang is an Associate Professor in the Department of Anatomy, Physiology and Pharmacology at Auburn University College of Veterinary Medicine . His research focuses on developmental endocrinology , particularly the regulatory mechanisms of endocrine organ development using mouse models and genome-wide analyses . Education: DVM, National Taiwan University PhD, University of Illinois at Urbana Champaign Postdoctoral Training, UCSF (2011) and NIH (2017) Dr. Huang's work investigates adrenal gland development , hedgehog signaling pathways , and steroid hormone synthesis . His lab employs molecular biology , next-generation sequencing , and bioinformatics to uncover mechanisms in adrenocortical growth and thyroid hormone interaction within endocrine organs.

Anastasios Lymperopoulosمشاهده پروفایل

دانشیار

• G protein-coupled receptors
• Heart Failure
• Cardiovascular Disease
• +۶ مورد دیگر

Anastasios Lymperopoulos, Ph.D., FAHA, FESC, is an Associate Professor in the Department of Pharmaceutical Sciences at Nova Southeastern University's Barry and Judy Silverman College of Pharmacy. He holds a Ph.D. in Pharmacology and M.Sc. in Medicinal Chemistry from the University of Patras, Greece. His research laboratory focuses on neurohormonal regulation in cardiovascular disease, specializing in G protein-coupled receptor (GPCR) pharmacology, adrenal-catecholamine signaling, and molecular mechanisms of heart failure. Research Interests: Dr. Lymperopoulos investigates GPCR kinase (GRK) and beta-arrestin pathways in adrenal aldosterone/catecholamine production, biased agonism at angiotensin receptors, RGS protein functions, and therapeutic targeting of epicardial fat in atrial fibrillation. Collaborative projects span universities in Italy (Federico II), Temple, Florida, and Miami. Recent Publications (2023-2025): Focus on cardiac GPCR signaling (GLP-1R, FFAR3), adrenal-kidney crosstalk in heart failure, SGLT2 inhibitor mechanisms (dapagliflozin), and metabolomics of epicardial fat. Trends highlight inflammation modulation, receptor crosstalk, and translational pharmacology. Awards & Honors: Fellow, American Heart Association (FAHA) and European Society of Cardiology (FESC) Scientist Development Grant, AHA (09SDG2010138) Finalist: Melvin L. Marcus Young Investigator Award & ESC Cardiovascular Research Award Grants & Patents: NIH R01 #HL155718-01 (Co-PI): Epicardial adipose tissue in atrial fibrillation U.S. Patent 10,172,907: Therapeutic modulation of aldosterone in heart disease Provisional patents: Adrenal GRK2 targeting and heart failure therapeutics Advising & Lab: Mentors PhD/PharmD students in cardiovascular research. Lab team studies adrenal GPCRs, GRK/β-arrestin pathways, and neurohormonal control via in vitro/vivo models.

Anne-Louise Gannonمشاهده پروفایل

پژوهشگر

• Endocrinology
• Nanobiotechnology
• Reproduction
• +۱۰ مورد دیگر

Anne-Louise Gannon is a Postdoctoral Research Associate at the University of Newcastle 's School of Environmental and Life Sciences , specializing in endocrinology , nanobiotechnology , and gene editing . She leads the Gannon Group laboratory on Callaghan campus and contributes to the HMRI Ignite Leadership Committee (2018-present). Education: PhD in Adrenal Hormone Regulation , University of Edinburgh (2018) MRes in Cancer Biology , University of Dundee (2014) Biology Honours, University of Dundee (2009) Research Focus: Her work bridges adrenal androgen signaling , nanotechnology for gene therapy , and transgenic mouse models . Key themes include adrenal disease therapeutics , single-injection sterilants , and stress hormone-testis interactions . She employs AAV9-Cre gene targeting , lipid-polymer nanoparticles , and in silico modeling . Publication Impact: Her 2016-2025 output spans ovarian cancer resistance mechanisms , adrenal X-zone biology , and nano-delivery systems , with first-author papers in Endocrinology , FASEB Journal , and Frontiers in Endocrinology . Notable 2024 work includes dual studies on HSD17B enzyme redundancy and microfluidic nanoparticle synthesis . Awards: New Investigator Award , 17th Annual Adrenal Cortex Conference (2016) HMRI Ignite Leadership Committee member Teaching: Lectures on Reproductive Physiology (BIOL3020) at UoN and mentored students through the Women in Reproduction initiative. Supervises PhD projects on epididymal-sperm epigenome links and adrenal nanotherapy .

Sara Galacمشاهده پروفایل

استادیار

• Veterinary Medicine
• Endocrinology
• Oncology
• +۵ مورد دیگر

Dr. Sara Galac is an Assistant Professor at the Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University. She is a clinical endocrinologist and researcher dedicated to a One Medicine approach, bridging veterinary and human medicine in endocrine oncology. Her work focuses on adrenal and pituitary tumors in companion animals, leveraging these models to address gaps in rare human cancers. Graduated from the Veterinary Faculty in Ljubljana, Slovenia PhD in Companion Animal Endocrinology (Utrecht University, 2010) Research interests span endocrine oncology , in vitro organoid models , and alternatives to animal testing . She leads the Oncology research group OnGo, pioneering pituitary/adrenal organoids for high-throughput drug screening and tumor biology studies. Her work integrates comparative endocrinology , cancer biomarkers , and 3D tissue modeling . Recent publications highlight advancements in canine pheochromocytoma and feline chronic kidney disease , with a focus on metabolomic profiling , drug efficacy , and diagnostic algorithms . Trends in her research emphasize cross-species tumor biology , novel therapeutic targets , and non-invasive biomarker development . 2024: NET-RF award 2019: Schimmel Virurly Prize 2010: Best Clinical Article (SCE in Denver) Galac actively participates in national/international grants , scientific communication , and public engagement through media contributions on veterinary oncology. She serves on PhD examination committees and promotes innovative animal models to reduce laboratory animal use.